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Abstract

In a common ROC study design, several readers are asked to rate diagnostics
of the same cases processed under different modalities. We describe a Bayesian
hierarchical model that facilitates the analysis of this study design by explicitly
modeling the three sources of variation inherent to it. In so doing, we achieve
substantial reductions in the posterior uncertainty associated with estimates of the
differences in areas under the estimated ROC curves and corresponding reductions
in the mean squared error (MSE) of these estimates. Based on simulation studies, both the widths of confidence intervals and MSE of estimates of differences
in the area under the curves appear to be reduced by a factor that often exceeds
two. Thus, our methodology has important implications for increasing the power
of analyses based on ROC data collected from an available study population.
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SUMMARY
In a common ROC study design, several readers are asked to rate diagnostics of the same cases
processed under different modalities. We describe a Bayesian hierarchical model that facilitates the
analysis of this study design by explicitly modeling the three sources of variation inherent to it. In
so doing, we achieve substantial reductions in the posterior uncertainty associated with estimates of
the differences in areas under the estimated ROC curves and corresponding reductions in the mean
squared error (MSE) of these estimates. Based on simulation studies, both the widths of confidence
intervals and MSE of estimates of differences in the area under the curves appear to be reduced by a
factor that often exceeds two. Thus, our methodology has important implications for increasing the
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power of analyses based on ROC data collected from an available study population. Copyright c
2004 John Wiley & Sons, Ltd.

INTRODUCTION
We propose a hierarchical latent variable model for analyzing multirater correlated ordinal
receiver operating characteristics (ROC) data. Recent research in ROC methodology has
focused on the inclusion of covariate effects and the combination of independent rating
information collected from multiple raters (e.g., [1, 2, 3, 4, 5]). An important and efficient
study design that has received less attention is one in which multiple readers rate several
diagnostic tests generated from data collected on the same subject. This design is common
in radiologic studies where, for example, radiologists evaluate images collected from the same
patient using distinct image modalities (e.g., PET, CT and MRI) or different reconstruction
algorithms within the same imaging modality. Outcomes from such a study design represent
correlated ordinal data. For the analysis of data collected in designs where only one reader rates
the outcomes, both parametric [6] and non-parametric methods [7, 8, 9] have been developed.
From a classical perspective, it is difficult to combine ROC data collected from several raters.
This difficulty is caused by the absence of a model component for rater variability, although
several methods have now been proposed to account for this source of variability (see, for
example [10, 11, 12]). Each of these methods require two stages of modeling. In the first
stage, estimates of the area under the ROC curve, commonly referred to as A Z , (and jackknife
pseudo-values of AZ ) for each rater are obtained. In the second stage, these estimates are
used as observations in a mixed-effects analysis of variance model. Further discussion of these
approaches may be found in Zhou, Obuchowshi and McClish (ZOM) [13].
Copyright c 2004 John Wiley & Sons, Ltd.
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The problem of combining information across raters is more transparent from the Bayesian
perspective, and several Bayesian approaches have now also been explored. Among the earlier
efforts in this direction are those detailed in Ishwaran and Gatsonis [3] and Johnson and Albert
[14]. In this article, we describe an hierarchical latent variable model for analyzing multirater
correlated ordinal ROC data that combines modeling aspects from each of these approaches and
others currently being developed. The primary innovation of this model over more commonly
used ROC models is the manner in which it accounts for three sources of variation inherent
in this study design; namely, variation in ratings attributable to differences in patient/subject
characteristics, variation in ratings introduced by inaccuracies in the procedures used to
define the diagnostic measure (modality effects), and variation attributable to readers of the
diagnostic test. By explicitly modeling these three sources of variation, Bayesian models for
ROC analysis are able to achieve substantial increases in power for detecting modality effects,
which are the primary variables of interest in most ROC studies. This partitioning of error
variances also facilitates the study of individual reader characteristics and provides a natural
mechanism for predicting the diagnostic performance of the test when interpreted by a reader
drawn randomly from the larger population of potential readers.

This article is organized as follows. In the next section we review, arguably, the most widely
used ROC model for the analysis of mulitrater correlated data, that of Dorfman, Berbaum
and Metz [10] (henceforth referred to as DBM). In Section we present a Bayesian hierarchical
model for the analysis of multirater correlated ROC data and highlight its connection to the
standard bivariate-binormal model (e.g., [15]). We compare performance of our model with
that of DBM in Section . Finally, we illustrate our model in the analysis of a radiological data
set intended to compare lung nodule detection using film versus a 1K display in Section . We
Copyright c 2004 John Wiley & Sons, Ltd.
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conclude the manuscript with a short discussion.

THE JACKKNIFE METHOD OF DBM
Arguably the most widely used method to analyze mulitrater correlated ROC data is that due
to DBM [10]. In this approach, reader ratings are jackknifed [16] to obtain pseudo-values for
the AZ for each case and modality one rater at a time. The pseudo-values are assumed to
behave as independent observations, and are subsequently entered into standard ME-ANOVA
software to fit a model of the form
Âijk = µ + αi + Bj + Ck + (αB)ik + (αC)ik + (BC)jk + (αBC)ijk + εijk .

(1)

In this equation, Âijk represents the AZ pseudo-value for test or modality i, reader j and case
k. We note that when each reader rates each image under each test only once (a common
study design), the terms (αBC)ijk and εijk are inseparable. In DBM, the overall mean µ
and the test effects αi are fixed with

P

i

αi = 0. The reader effects, Bj , case effects, Ck ,

interaction terms and model error are assumed to be mutually independent, mean zero normal
2
2
2
2
2
2
and σε2 , respectively. Typically,
, σαBC
, σBC
, σαC
, σαB
, σC
random deviates with variances σB

differences between treatment means are assessed using Satterthwaite-approximate F tests [17].
Confidence intervals for parameters of interest are constructed using an approximate Studentt distribution, although approximate confidence intervals for treatment means may also be
derived using a reduced model defined by omitting all but the rater-by-case interaction terms.
ZOM summarize three shortcomings of this approach which we paraphrase here. First,
pseudo-values are treated as observed data. Using pseudo-values as observed data has only
limited utility, and previous attempts to extract more than variance estimates from pseudoCopyright c 2004 John Wiley & Sons, Ltd.
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values have not been successful [16]. Second, pseudo-values are, in general, correlated. This
means that the ME-ANOVA assumption of independent observations is violated. Third, this
method applies the one-sample jackknife to a two sample problem (diseased and healthy
cases). Finally, we note that the AZ is supported on the interval [0, 1], but observed pseudovalues often take values outside this interval. In practice, then, there are important differences
between pseudo-values for AZ and independent AZ observations. Despite these theoretical
shortcomings, this method enjoys much success in the radiological sciences.
Subsequent to the work of DBM, two other maximum-likelihood-based approaches have
been developed [11, 12]. Both approaches follow along the same lines as that of DBM. At
the first stage of modeling, AZ values are computed one rater at a time. At the second stage
of modeling, the AZ values are combined across raters and modalities using a ME-ANOVA
model. Both models have been compared to the DBM model with results comparable to that
of DBM [11, 12] and so are not presently compared. A short summary and critique of each is
provided in ZOM.

A BAYESIAN HIERARCHICAL MODEL
For the remainder of the paper, we assume that a panel of readers have assessed the disease
status of a population of controls and cases to produce ordinal ratings based on two or more
diagnostic tests (modalities). In performing our analysis, we assume that we know the true
disease status of all subjects. The model proposed here is closely related to a simpler model
described in Johnson and Albert [14], and may be considered approximately as a special
case of the model proposed in Ishwaran and Gatsonsis [3]. The primary generalization of this
model over that described in Johnson and Albert is the inclusion of a more flexible class of
Copyright c 2004 John Wiley & Sons, Ltd.
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prior distributions on model parameters. In contrast to the model proposed in Ishwaran and
Gatsonis we do not incorporate a regression model for the underlying latent variables, nor do
we consider semi-parametric link functions to account for non-normality of the latent trait
distributions. However, as Ishwaran and Gatsonis point out, such link functions are probably
not necessary (or estimable) when ROC data are collected using a small number of categories
(the case in which we are interested). We do, however, extend the Ishwaran and Gatsonis
model by allowing for distinct rater thresholds for each rater.

Suppose then there are Nh healthy cases and Nd disease cases for total of N = Nh + Nd
subjects. Let D denote the set of subjects classified as diseased and let H denote the set
of subjects classified as being healthy. Let J > 1 denote the number of readers of each
diagnostic test and assume that each reader rates subjects who are diseased and healthy
using measurements derived from each diagnostic test. Let K > 1 denote the number of
tests or diagnostic measures available to readers for evaluating each case, and suppose, for
simplicity, that each subject is placed into one of C ordered categories by each reader under
each test. The observed rating from reader j scoring case i under test k is denoted by
Yijk . We adopt the convention that larger values of Yijk are indicative of a higher degree
of confidence that the subject is diseased. We assume the latent variable representation for
the data Y = {Yijk } detailed in Johnson and Albert. Under this representation, the ordinal
ratings of each case by each reader are hypothesized to result from the (possibly distorted)
observations of a continuous, scalar-valued random variable representing the presence of a
disease attribute. The distribution of this latent disease attribute is assumed to be drawn from
one of two distributions, one for healthy subjects and one for diseased individuals. We adopt
the binormal assumption and assume that these distributions are Gaussian. The practicality
Copyright c 2004 John Wiley & Sons, Ltd.
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of this assumption is discussed in Swets and Pickett [15], where an argument is presented
to suggest that even non-Gaussian continuous data can be adequately represented under this
model (when thresholds for the ordinal categories are estimated from data). The generality
of this assumption is clarified further in Pepe [18], who provides a proof that there exists
a monotone transformation of the continuous data to make the distributions of the healthy
group and that of the diseased group normal.
In the first level of our model, we assume that the latent (disease) trait for the ith subject,
denoted by Zi , follows a normal distribution. We assume that the latent value for healthy cases
is marginally distributed as a N (0, 1) random variable, while the latent value for a diseased
individual is distributed as a N (µ, ψ 2 ) random variable. We treat the parameters µ and ψ 2 as
unknown parameters and estimate them from data (see Figure 1, panel A). At the second level
of the hierarchy, we assume that a N (0, φ2k ) error is added to each latent disease trait. This
error term accounts for inaccuracies and distortions introduced by the diagnostic modality.
The parameter φ2k denotes the variance of this error for modality k (Figure 1, panel B). The
parameter Zik denotes the value of the latent trait of case i that would be observed by an ideal
rater (a rater who scores the cases with no variability) using modality k. At the final stage of
the model hierarchy, we assume that the value of Zik is further distorted by the addition of a
N (0, θj2 ) random variable that represents error attributable to the jth reader’s observation of
Zik . The parameter θj2 denotes the error variance particular to the jth reader. The sum of Zik
and the reader error for the jth reader is denoted by Zijk (Figure 1, panel C).
In assigning cases to categories, we assume that each reader uses a unique set of thresholds
γ j having components that satisfy −∞ = γj0 < γj1 < · · · < γjC−1 < γjC = ∞. Reader
j assigns case i under modality k to category c if Zijk falls between the (j − 1)st and jth
Copyright c 2004 John Wiley & Sons, Ltd.
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threshold. That is, Yijk = c if and only if γjc−1 < Zijk ≤ γjc .
To summarize the hierarchical model as specified thus far, we have
iid

Zi ∼ N (0, 1), ∀ i ∈ H

iid

and Zi | µ, ψ 2 ∼ N (µ, ψ 2 ), ∀ i ∈ D

Level 1

(2)

Zik | Zi , φ2k ∼ N (Zi , φ2k ), ∀ k

Level 2

(3)



p(Zijk | Zik , θj2 ) = (K/θj ) exp −0.5(Zijk − Zik )/θj )2 ×

Level 3

(4)

iid

I(γjyijk −1 < Zijk ≤ γjyijk )

The right hand side of (4) is a truncated normal density with normalizing constant K and
I(A) is the indicator function with I(A) = 1 if A is true and is equal to zero otherwise.
Heuristically, this model may be interpreted as follows. First, latent disease traits for
individuals in the population have inherent variability, and the magnitude of this variability is
different among diseased and non-diseased individuals. Without loss of generality, we assume
the variance of the latent traits among the non-diseased population is one, and among the
diseased population is ψ 2 . Second, measurements made by a diagnostic test or modality
introduce errors in the observation of a case’s latent disease trait. The variance of the error for
the kth diagnostic test is denoted by φ2k . Finally, readers’ interpretations of diagnostic tests
are subject to error, and we allow for the possibility that different readers may have different
expertise. The variance of the jth reader’s error contribution is denoted by θ j2 .
To specify prior constraints on parameters appearing in (2)-(4), we adopt the following prior
factorization:



J
Y

j=1



π(γ j )π(θj2 )

K
Y

k=1

π(φ2k

|

θ12 , . . . , θJ2 )

!

π(µ) π(ψ 2 ).

For ψ 2 , we take an inverse gamma prior distribution with parameters 3 and 3 (i.e., IG(3, 3)).
Under the parametrization of the inverse gamma distribution adopted here, this distribution
Copyright c 2004 John Wiley & Sons, Ltd.
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has a mean of 1.5 and a mode of 0.75. This reflects a prior constraint that variability in the
disease population is typically larger than in the healthy population. Ninety percent of the
mass of this prior lies between 0.48 and 3.7 (equal tail areas). We place an improper uniform
prior on the disease population mean, µ.
Some care must be exercised in specifying the priors for modality and reader variances.
Because the scale of the “observed” latent variables Zijk is not well defined from the priors
specified on the distribution of the latent disease traits Zi , application of non-informative
priors on both the components of {φ2k } and {θj2 } can result either in a rater or modality
variance collapsing to zero—resulting in a marginal posterior density that becomes highly
peaked around zero—or variances that becomes arbitrarily large as category thresholds and
all “observed” latent traits become large simultaneously.
These problems can be avoided by using uniform shrinkage priors for the modality variances.
The Uniform shrinkage prior–first proposed by Strawderman [19]–represent a relatively vague
but proper prior specification. These priors derive their name from the fact that they place a
uniform distribution on the shrinkage of a posterior mean toward a prior mean in simple linear
models. More recently, they were investigated by Daniels [20] and Natarajan and Kass [21].
Daniels showed they possess favorable frequentist properties, particularly when compared to
other commonly used non-informative priors for variance components. To define the uniform
priors specified here, let Hθ denote the harmonic mean of the θj2 : Hθ = J/
consider the conditional posterior expectation of Zik :

E(Zik | Zi , φ2k , Zijk , θj2 , j = 1, . . . , J) =

PJ

−2
j=1 θj

and

J
Hθ φ2k X
Hθ
Zijk /θj2 +
Zi .
Jφ2k + Hθ j=1
Jφ2k + Hθ

The uniform shrinkage prior for φ2k can be induced by placing a uniform prior on the shrinkage
Copyright c 2004 John Wiley & Sons, Ltd.
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parameter Hθ /(Jφ2k + Hθ ) and applying the appropriate transformation of variables. Thus
π(φ2k | θ12 , . . . , θJ2 ) = Hθ /(Jφ2k + Hθ )2 ,

k = 1, . . . , K.

(5)

In contrast to the improper priors mentioned above, the uniform shrinkage prior puts
arbitrarily small mass in neighborhoods of zero, thus avoiding a collapse of one or more of
the marginal posterior distributions on the variance parameters to zero. In conjunction with
this uniform shrinkage prior on the components of {φ2j }, we take improper uniform priors on
the rater variances {θj2 }.
With this choice of priors for the reader and modality variances, propriety of the posterior
distribution depends on the choice of prior density for the reader thresholds. The prior densities
specified for the thresholds in Ishwaran and Gatsonis [3], which are uniform for the components
of γjc on a finite interval (subject to an obvious order constraint), is adequate to establish a
proper posterior. However, the posterior distribution on both the components of γ j and the
variance components φ and θ are sensitive to the length of the interval chosen. To overcome
the sensitivity in the posterior to the choice of interval length, we induce a prior density for the
category thresholds by assigning probabilities to the event that a randomly selected subject
would be categorized into category c by an ideal rater (zero variance) under an ideal modality
(zero variance). The prior density induced in this way has support over the real line. To define
the specific form of this prior, let
F (x) =

Nh
Nd
Φ(x; 0, 1) +
Φ(x; 1.07, 1.5)
N
N

where Φ(x, µ, σ 2 ) is the cdf of a normal distribution with mean µ and variance σ 2 . Here, the
disease group variance has been set to its prior mean and the disease group mean has been set
to 1.07, which lead to an ideal AZ of about 0.75. This value is midway between the minimum
Copyright c 2004 John Wiley & Sons, Ltd.
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informative value of 0.5 and the maximum of 1.0. Define the probability that a subject is placed
in category c under this idealized rating scheme by pjc = F (γjc ) − F (γjc−1 ), for c = 1, . . . , C.
Then our prior density for the category thresholds is obtained by placing a Dirichlet prior on
the pj = {pj1 , . . . , pjC } and transforming to the γ scale to obtain
π(γ j ) ∝ J

C
Y

c=1

{(Nh /N ) [Φ(γjc ; 0, 1) − Φ(γjc−1 ; 0, 1)] +

(6)

(Nd /N ) [Φ(γjc ; 1.07, 1.5) − Φ(γjc−1 ; 1.07, 1.5)]}

(2−1)

.

Here, J is the Jacobian of the transformation. The parameters of the Dirichlet prior effectively
place 2 observations, a priori, in each category for each reader. This prior prevents the escape
of the reader thresholds to ±∞, but imposes only weak information about the values of the
reader thresholds. This completes the specification of the model.

CONNECTION TO THE BIVARIATE-BINORMAL MODEL
We now compare the distributional assumptions implicit in our hierarchical Bayesian model for
ROC data with the assumptions implicit to the classical bivariate-binormal model. To this end,
we adopt the following simplified notation and assume that interest focuses on a comparison of
only two diagnostic tests for one particular rater. Let Aj be a two-by-two diagonal matrix with
diagonal elements (1+φ21 +θj2 )−1/2 and (1+φ22 +θj2 )−1/2 . If we marginalize over {Zi } and {Zik }
in (2), (3), and (4) and apply the transformation of variables (Xij1 , Xij2 )T = Aj (Zij1 , Zij2 )T ,
we find that the marginal distribution for the latent traits observed under each modality for a
healthy case under our Bayesian hierarchical model can be expressed as
(Xij1 , Xij2 )T ∼ Φ2 ((0, 0)T , Σh ),

(7)

where Φ2 denotes a bivariate normal distribution. Similarly, the marginal distribution for the
latent traits observed under each modality of a diseased case under the Bayesian model can
Copyright c 2004 John Wiley & Sons, Ltd.
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be expressed
(Xij1 , Xij2 )T ∼ Φ2 ((µ1 , µ2 )T , Σd ).

(8)

Conditionally on the observed values, yij , of Yij the latent trait distributions are truncated to
the the interval (γjyij1 −1 , γjyij1 ]Aj × (γjyij2 −1 , γjyij2 ]Aj , where
µ1 = q

and




Σh = 




Σd = 


µ
1 + φ21 + θj2

µ
and µ2 = q
,
1 + φ22 + θj2

1

√

1+θj2
(1+φ21 +θj2 )(1+φ22 +θj2 )

1+θj2
(1+φ21 +θj2 )(1+φ22 +θj2 )

√

ψ 2 +φ21 +θj2
1+φ21 +θj2
ψ +θj2
2
(1+φ1 +θj2 )(1+φ22 +θj2 )

√

2

1

√

ψ 2 +θj2

(1+φ21 +θj2 )(1+φ22 +θj2 )
2

ψ +φ22 +θj2
1+φ22 +θj2




,




.


Equations (7) and (8) reflect the distributional assumptions made for the latent variables in
the standard bivariate-binormal model. However, in the standard bivariate-binormal model, the
covariance matrix of the latent traits for the disease population between the two diagnostic tests
is completely arbitrary. So is the correlation between the two tests in the healthy population.
In the hierarchical Bayesian model, the equations for the marginal covariance matrices given
above imply that the correlations between traits is forced to be positive. We feel that this
is a reasonable constraint to impose on the covariance between latent traits observed for the
same subject, making this a feature rather than a drawback of the model. Furthermore, the
standard bivariate-binormal model can only be applied to data from one rater at a time,
thus the need for a second stage ME-ANOVA model in the commonly used likelihood-based
approaches previously mentioned.
Copyright c 2004 John Wiley & Sons, Ltd.
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MCMC DETAILS
The complexity of the joint posterior distribution on model parameters precludes the analytical
study of posterior expectations. For that reason, we rely on Markov chain Monte Carlo
(MCMC) methodology to generate samples from the posterior distribution and base model
inferences on these sampled values.

After initializing model parameters, the particular steps in the MCMC scheme we propose
may be described as follows.

1. Sample ψ 2 ∼ IG(3 + 0.5Nd, 3 + 0.5
2. Sample µ ∼ N (

P

i∈D

P

i∈D (Zi

− µ)2 ).

Zi /Nd , ψ 2 /Nd ).

3. For i ∈ H, sample Zi ∼ N (mh , vh2 ) where mh = vh2

P

k

2
Zik φ−2
k and vh = (1 +

4. For i ∈ D sample Zi ∼ N (md , vd2 ) where md = vd2 (µψ −2 +
(ψ −2 +

P

k

−1
φ−2
.
k )

P

k

−1
φ−2
.
k )

Zik φ−2 ) and vd2 =

5. For k = 1, . . . , K draw a candidate value φ2k∗ ∼ IG(−1 + N/2, 0.5


Accept φ2k∗ with probability min 1, (Hθ + Jφ2k )2 /(Hθ + Jφ2k∗ )2 .

P

PN

i=1 (Zik

− Zi )2 ).

2
2
(Zi φ−2
) where mik = vik
6. For i = 1, . . . , N and k = 1, . . . , K, sample Zik ∼ N (mik , vik
k +

P

j

2
= (φ−2
Zijk θj−2 ) and vik
k +

P

j

θj−2 )−1 .

2
7. Draw a candidate value θj∗
∼ IG(−1 + N K/2, 0.5

PN PK
i=1

k=1 (Zijk

− Zik )2 ) for j =



2
1, . . . , J. Accept θj∗
with probability min 1, (Hθ + Jφ2k )2 /(Hθ∗ + Jφ2k )2 .

8. For j = 1, . . . , J and for c = 1, . . . , C − 1 draw γjc∗ from a truncated normal distribution
with mean γjc and variance V , truncated to (γjc−1∗ , γjc+1 ) where γj0∗ ≡ −∞ and
Copyright c 2004 John Wiley & Sons, Ltd.
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γjC∗ ≡ ∞. Let γ j∗ = (γj1∗ , . . . , γjC∗ ). Accept γ j∗ as the new value of γ j with probability
min 1,

N Y
K
π(γ j∗ | µ, ψ 2 , θj2 , φ21 , . . . , φ2K ) Y
Φ(γjyijk ∗ ; Zik , V ) − Φ(γjyijk −1∗ ; Zik , V )
π(γ j | µ, ψ 2 , θj2 , φ21 , . . . , φ2K ) i=1
Φ(γjyijk ; Zik , V ) − Φ(γjyijk −1 ; Zik , V )
k=1
!
C−1
Y Φ(γjc+1 ; γjc , V ) − Φ(γjc−1∗ ; γjc , V )
×
.
Φ(γjc+1∗ ; γjc∗ , V ) − Φ(γjc−1 ; γjc∗ , V )
c=1

V was chosen so that the acceptance rate was approximately 35%. This MetropolisHastings strategy for updating the category thresholds was proposed by Cowles [22].
9. For all i, j and k, draw Zijk ∼ N (Zik , θj2 ) truncated to the interval (γjyijk −1 , γjyijk ].
Samples from the posterior distribution on the model parameters can be used to obtain
posterior samples of AZ values as follows. Let Wjk denote the latent variable of a randomly
chosen healthy individual from rater j under condition k and let Ujk denote the latent variable
of a randomly chosen diseased individual. Then, AZ jk = Pr(Wjk < Ujk ) yields a sample
from the posterior distribution of the AZ for rater j under condition k [7]. From the model
assumptions, it follows that AZjk = 1 − Φ(0; µ, 1 + ψ 2 + φ2k + θj2 ). Similarly, we define the AZ
for an ideal rater as the AZ for a rater with zero variance. The AZ for such a rater is denoted
by AZ k and is equal to 1 − Φ(0; µ, 1 + ψ 2 + φ2k ).

SIMULATION STUDIES

In this section we examine the frequentist properties of our model. The particular parameters
that we examine include AZ s obtained for individual modalities and differences in AZ s obtained
from an ideal rater, as well as ratios of rater variances (note that absolute magnitudes of rater
variances are only defined relative to the prior densities assumed for the latent traits). We also
compare the coverage of posterior probability intervals to their nominal values, and compare
the lengths of these intervals to the lengths of the corresponding intervals generated using the
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DBM models. Finally, we examine the mean squared error (MSE) of the AZ and differences
of AZ s computed from our Bayesian hierarchical model and the multirater method of DBM.
A difficulty that arose in performing this simulation study involved the selection of study
populations. Clearly, if we had chosen to simulate data according to our prior model, then
the posterior properties of parameter estimates would be optimal and little would be learned
concerning the relative performance of our model to alternative formulations. Alternatively, we
might have compared parameter estimates obtained from different models for the same data,
but this is also problematic since the baseline truth for the data is then not known. Because
of these difficulties, we decided to perform two simulation studies. In the first, we drew model
parameters from prior densities that differed markedly from the prior densities assumed in
our formulation, and then used these parameters to generate ROC data. These data were
then analyzed using our model and the model described by DBM. In the second simulation,
we identified a real ROC data set in which both models generated similar estimates of the
difference in AZ values. After adding random noise to these data, we then used a resampling
procedure to obtain smaller samples from this data set, and then compared AZ estimates
obtained under each model based on the subsampled data to the AZ estimates obtained under
that model using the full data set.

SYNTHETIC DATA
In this simulation, we repeatedly generated ROC data from a hierarchical model that had
a structure similar to our Bayesian hierarchical model, but which used different priors on
model parameters. In particular, the data generating model used values of µ drawn from a
U (0, 3) distribution (an improper prior was used in the estimation model), values of ψ 2 drawn
Copyright c 2004 John Wiley & Sons, Ltd.
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from a U (0.5, 3) distribution (an IG(3,3) distribution is used in the estimation model), and
modality variances φ2k and rater variances θj2 drawn independently from a U (0.1, 3) distribution
(uniform shrinkage and improper prior densities were assumed for φ2k and θj2 , respectively, in
the estimation model). Figure 2 gives a visual comparison of the model priors and the priors
used to generate the synthetic data.
We simulated 1000 data sets, each with parameters drawn from the distributions just
described. Each data set consisted of 100 healthy and 100 diseased cases, each rated by four
readers based on observations generated from two diagnostic tests. A 5-point rating scale was
used. For simplicity, category thresholds were drawn from their actual prior distribution. After
generating model parameters, latent variables Zi , Zik and Zijk were generated according to
(2)-(4). Ordinal data values Yijk were then determined according to the rule Yijk = c if and
only if Zijk ∈ (γjc−1 , γjc ]. Posterior distributions were estimated from 150,000 iterations after
a burn-in of 100,000 iterations. One MCMC simulation took approximately 17.5 minutes on a
PowerMac G4, 1.42 GHz processor.
AZ coverage rate, interval lengths and MSE from our model and those from DBM are
presented in Table I. AZ statistics for the hierarchical Bayesian model correspond to the AZ
for an ideal rater.
For the study of a single modality, from Table I we see that the DBM model provides more
accurate coverage of AZ values than the Bayesian model. Coverage of the Bayesian model is
slightly low. When considering only a single modality, the average length of the 95% confidence
interval for the AZ and the MSE of the estimate of the AZ values were comparable for the
DBM and Bayesian models.
In most ROC studies, the parameters of primary interest are differences in AZ areas between
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modalities. For such differences, our Bayesian model provides important gains in efficiency.
For example, the average length of the confidence interval for the difference in A Z areas
between two modalities obtained from the Bayesian model is only about 1/2 as wide as the
corresponding confidence interval obtained using the DBM model. Similarly, the MSE error
for the difference in AZ values under the Bayesian model is only 1/3 as large as the MSE of the
DBM models. This gain in precision is attributable to two factors. First, biases inherent in the
Bayesian estimates of the AZ areas largely cancel when differences in areas are examined. In
this regard, it is important to note that the distribution of parameter values used to generate
the simulated data differed substantially from the prior models used for estimation. Second,
because the distribution of differences in AZ values are computed with respect to the joint
posterior distribution in the Bayesian model, the positive correlation between simulated values
of the AZ attributable to common draws of the rater variances reduces the variance of the
distribution of the difference, much as it does in a paired t-test. The classical methods cannot
exploit this covariance because it is not reflected in the marginal distribution of AZ (or AZ
pseudo-values) values used in the follow-on ME-ANOVA analyses. Finally, it is interesting to
note that the coverage rate for the difference in modality AZ values is best for the Bayesian
model.

Table I. AZ 95% Coverage Rates, interval lengths and MSE. Comparison with the DBM model.
Coverage Rates

Interval lengths

MSE

Modality

Difference

Modality

Difference

Modality

Difference

Bayes

91.6

94.7

0.113

0.064

0.00115

0.00029

DBM

96.0

93.6

0.132

0.139

0.00097

0.00118
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Coverage rates for ratios in the values of rater variances obtained from within the Bayesian
model were close to their nominal values. The coverage of 95% posterior probability intervals
was 95.4 in repeated sampling in this simulation study.

RESAMPLING CORRUPTED ROC DATA
An unpublished ROC study was conducted in 1993 in the UCLA Department of Radiology. The
purpose of this study was to compare the diagnostic capabilities of chest film radiographs to
digitized film displayed on a 1K by 1K video display. The basis of comparison were radiologists’
abilty to detect lung nodules in the radiographs. A panel of expert radiologists determined
“truth” by consensus on 772 archived chest radiographs (59 cases with nodules and 713 disease
free cases). Each of the 772 radiographs were then digitized for video display.
Three experienced radiologists and two radiology residents read each case under both
systems (film vs. video display) and ranked the presence of nodules on a scale of 1 to 5.
Large ratings represented high confidence that nodules were present. We analyzed this data
with the Bayesian hierarchical model and the method proposed by DBM. The outcome of
interest was the difference in AZ s. For the complete data set, the estimated posterior mean
difference in AZ s (film - video display) under the Bayesian model was -0.0002 with a 95%
posterior probability interval (−0.003, 0.002) (equal tail areas). From this, we conclude that
the AZ values for the two methods are not substantively different.
When we attempted to apply the DBM method to these data, we experienced two numerical
problems. First, the ratings obtained from one of the radiologists was “degenerate”. That is
to say the likelihood method used to compute AZ s and pseudo-values was unable to produce
AZ s for that rater because of the lack of variation in his/her ratings of images. Second, while
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jackknifing several of the cases for the other radiologists, the likelihood methods failed to
converge. As a consequence, we were unable to obtain reliable estimates of A Z values for the
full data set using the DBM method.
Because of these convergence problems, the second simulation study was carried out using a
contaminated version of the data. Noise was added to the data set by randomly choosing half
the cases, and for each selected case randomly changing all radiologist’s rating of that case by
1 unit with probability .2 for ratings between 2 and 4, and with probability .1 for ratings of 1
and 5. For example, if a case’s rating by a radiologist was 2, then with probability .1 it was
changed to a 1 and with probability .1 it was changed to a 3. For the extreme ratings of 1 and
5, with probability .1 the rating was changed by 1 unit toward the center of the rating scale.
The contaminated data set was then analyzed under each model, and the point estimates so
obtained were subsequently assumed to represent the “truth” for the corresponding modality.
For the likelihood-based models, the average rater AZ for film was .717 and for the video
display .698. The difference was .019. For the Bayesian model, the ideal rater A Z for film was
.801 and for video display .807; the difference in AZ values was -0.006. The AZ differences
were not significantly different from zero under all models considered.
The contaminated data was then repeatedly resampled with replacement. In each data set
simulated in this way, 150 samples from the “healthy population” were sampled and 50 samples
from the “diseased population” were sampled. A total of 1,000 ROC data sets were obtained
in this way.
A summary of AZ coverage rates, interval lengths and MSE values obtained from these 1,000
simulated data sets appear in Table II. Qualitatively, the results in Table II are similar to those
reported in Table I. Coverage rates for individual modality AZ values are more accurate under
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the DBM model than they are under the Bayesian model. For differences in AZ values, the
DBM model provides somewhat low coverage, while coverage for the difference in A Z values is
high for the Bayesian model. Interval lengths of the individual AZ values and their difference
are shortest for the Bayesian model. Both methods have comparable MSE values for individual
modality AZ values. However, the Bayesian model provides the smallest MSE for the difference
in AZ values. The MSE is nearly 7 times smaller than that provided by the DBM model.
Table II. AZ 95% Coverage Rates, interval lengths and MSE under resampling from the contaminated
data set
Coverage Rates

Interval lengths

MSE

Film

Video

Diff.

Film

Video

Diff.

Film

Video

Diff.

Bayes

91.6

91.5

99.5

0.186

0.188

0.041

0.0032

0.0033

0.00050

DBM

94.8

97.7

93.6

0.267

0.326

0.217

0.0036

0.0029

0.00330

DISCUSSION
The Bayesian hierarchical model described in this article provides a new approach towards
analyzing multirater correlated ROC data. The primary advantage of this approach over
existing methods is a marked decrease in the length of confidence intervals associated with
differences in AZ values and corresponding decreases in the MSE of these differences. In our
simulation studies, confidence interval lengths were reduced by a factor of more than 2, while
MSEs were reduced by a factor greater than 3. These finding have important implications for
study design and the power of ROC analyses for detecting differences in AZ s.
Aside from increases in the efficiency of the model, this framework provides reliable estimates
Copyright c 2004 John Wiley & Sons, Ltd.

Statist. Med. 2004; 00:1–28

Prepared using simauth.cls

http://biostats.bepress.com/umichbiostat/paper28

21

BAYESIAN ROC ANALYSIS

of ratios of rater variances, and so has the potential for providing feedback to readers regarding
their precision in rating subjects relative to their peers. A similar potential also exists for the
model to help readers calibrate their category thresholds.
Computer programs to implement the models described in this paper are available from the
authors’ website.
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(A) Level 1

(B) Level 2
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Figure 1. Graphical representation of our Bayesian hierarchical model. Panel A: The distributions of
the latent case traits. Panel B: Modality k adds noise to the latent trait Zi . Panel C: Rater j adds
more noise to the system centered at Zik . The dashed vertical lines represent hypothetical perceived
values.
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Figure 2. Graphical representation of the priors used for data generation (dashed lines) and the model
priors (solid lines). UL: Priors for µ. UR: Priors for ψ 2 . LL: Priors for φ2k . The uniform shrinkage prior
assumes J = 4 and θj2 = 1, j = 1, 2, 3, 4 [see (5)]. LR: Priors for θj2 .

Copyright c 2004 John Wiley & Sons, Ltd.

Statist. Med. 2004; 00:1–28

Prepared using simauth.cls

http://biostats.bepress.com/umichbiostat/paper28

